Riskpilot← Back to searchSign inGet full accessSVANEKLINIK ApS
APSActiveCVR 31609135Lyngby Hovedgade 27, 2.Retail sale of medical and orthopaedic goods · NACE 4774Est. 20085 employees
Revenue 2024
DKK 3M
+4% vs 2023
EBITDA margin
27.0%
+326% vs 2023
Equity ratio
64.0%
Financial strength
Net profit 2024
DKK 647K
+326% vs 2023
| Revenue | DKK 3M | +4% |
| EBITDA | DKK 815K | +326% |
| Net profit | DKK 647K | +326% |
| Total assets | DKK 2,5M | +28% |
| Equity | DKK 1,6M | +53% |
| Employees | 5 | — |
Legal name
SVANEKLINIK ApS
CVR number
31609135
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
30. juni 2008
Share capital
DKK 125.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med bestyrelsesformanden
eller af den samlede bestyrelse.
Company purpose
Selskabets formål er import af og videresalg af hjælpemidler til cancerpatienter.
Address
Lyngby Hovedgade 27, 2.
Phone
+4545870110
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2.620 | 2.960 | 2.746 | 2.893 | 3.015 |
| Staff expenses | -2.030 | -2.136 | -2.427 | -2.702 | -2.199 |
| EBITDA | 590 | 824 | 320 | 191 | 815 |
| Depreciation & amort. | -4 | -8 | -0 | -0 | -0 |
| EBIT | 586 | 817 | 320 | 191 | 815 |
| Net financials | 9 | 18 | 15 | 8 | 21 |
| Profit before tax | 595 | 835 | 335 | 199 | 837 |
| Tax | 135 | 188 | 78 | 48 | 190 |
| Net profit | 461 | 647 | 257 | 152 | 647 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.652 | 2.475 | 1.817 | 1.921 | 2.454 |
| Equity | 1.369 | 1.516 | 1.123 | 1.025 | 1.572 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.283 | 959 | 693 | 896 | 883 |
| Total debt | 1.283 | 959 | 693 | 896 | 883 |
EBITDA margin
27.0%
This company
15.8%
Market median
+71% vs market
20202024
Equity ratio
64.0%
This company
38.2%
Market median
+68% vs market
20202024
Return on equity
41.1%
This company
18.4%
Market median
+123% vs market
20202024
Net profit margin
21.5%
This company
8.1%
Market median
+165% vs market
20202024
Asset turnover
1.23×
This company
1.12×
Market median
+10% vs market
20202024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PH Founder | Founder | 2008 |
IK Management | Management | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HERRAS Holding ApS
SVANEKLINIK ApS Board members of SVANEKLINIK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pia Hermann | Founder | 0 companies |
| Iben Katrine Hermann Rasmussen | Management | 0 companies |
| Hans Henrik Hermann Rasmussen | Chairman | 0 companies |
| Gregers Gautier Hermann | Board of Directors | 0 companies |